Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

46.08
+1.984.49%
Post-market: 47.401.32+2.86%18:06 EST
Volume:1.21M
Turnover:55.10M
Market Cap:3.56B
PE:-11.86
High:46.25
Open:43.86
Low:43.86
Close:44.10
52wk High:46.60
52wk Low:26.74
Shares:77.28M
Float Shares:71.60M
Volume Ratio:1.34
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8866
EPS(LYR):-3.0083
ROE:-45.14%
ROA:-29.51%
PB:6.36
PE(LYR):-15.32

Loading ...

Nov 16, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Major Issues Report

8-K - Current report
Sep 08, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 03, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 10, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jan 14, 2021

Major Issues Report

8-K - Current report